Human cytomegalovirus (HCMV) is a widespread pathogen that is the leading viral cause of birth defects and a major cause of morbidity and mortality in adults who are immunocompromised. Although HCMV has not been shown to play a direct causative role in human cancer, it impacts cancer patients as an opportunistic infection, and several of its gene impacts exhibits oncogenic or mutagenic activity or modulate cell cycle progression, influencing cell growth. Its interaction with an infected host is complex. HCMV can undergo latency in some cell types and actively replicate to produce infectious progeny in a variety of other cell types. Given its prominence as a human pathogen, it is essential that we continue to advance our understanding of the molecular mechanisms that underlie HCMV replication and pathogenesis. The long-term objectives of this research program are to elucidate the role of cellular genes in HCMV replication and to identify the differences in the interaction of HCMV with its host cell that lead to productive replication as compared to latency. This proposal builds on preliminary studies in which cellular mRNAs whose steady state levels are modulated by HCMV have been identified, and it includes two specific aims: (1) determine the mechanism by which HCMV alters cellular gene expression, and elucidate the physiological consequences of these changes; and (2) assay HCMV gene expression in latently infected cells, and investigate the functions of viral genes that are identified. This research program will benefit from technical and intellectual synergies, as well as from the opportunity for comparative studies, provide by the program project grant format.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA087661-02
Application #
6484150
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2001-08-01
Project End
2002-07-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Princeton University
Department
Type
DUNS #
002484665
City
Princeton
State
NJ
Country
United States
Zip Code
08544
Kramer, Tal; Greco, Todd M; Taylor, Matthew P et al. (2012) Kinesin-3 mediates axonal sorting and directional transport of alphaherpesvirus particles in neurons. Cell Host Microbe 12:806-14
Lee, Sungwook; Sakakibara, Shuhei; Maruo, Seiji et al. (2009) Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1. J Virol 83:12368-77
Sciortino, Maria Teresa; Taddeo, Brunella; Giuffre-Cuculletto, Maria et al. (2007) Replication-competent herpes simplex virus 1 isolates selected from cells transfected with a bacterial artificial chromosome DNA lacking only the UL49 gene vary with respect to the defect in the UL41 gene encoding host shutoff RNase. J Virol 81:10924-32
Taddeo, Brunella; Zhang, Weiran; Roizman, Bernard (2006) The U(L)41 protein of herpes simplex virus 1 degrades RNA by endonucleolytic cleavage in absence of other cellular or viral proteins. Proc Natl Acad Sci U S A 103:2827-32
Brukman, Alla; Enquist, L W (2006) Suppression of the interferon-mediated innate immune response by pseudorabies virus. J Virol 80:6345-56
Liang, Yu; Roizman, Bernard (2006) State and role of SRC family kinases in replication of herpes simplex virus 1. J Virol 80:3349-59
Kamiyama, H; Zhou, G; Roizman, B (2006) Herpes simplex virus 1 recombinant virions exhibiting the amino terminal fragment of urokinase-type plasminogen activator can enter cells via the cognate receptor. Gene Ther 13:621-9
Liang, Li; Roizman, Bernard (2006) Herpes simplex virus 1 precludes replenishment of the short-lived receptor of tumor necrosis factor alpha by virion host shutoff-dependent degradation of its mRNA. J Virol 80:7756-9
Paulus, Christina; Sollars, Patricia J; Pickard, Gary E et al. (2006) Transcriptome signature of virulent and attenuated pseudorabies virus-infected rodent brain. J Virol 80:1773-86
Zhao, Bo; Maruo, Seiji; Cooper, Andrew et al. (2006) RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines. Proc Natl Acad Sci U S A 103:1900-5

Showing the most recent 10 out of 74 publications